Brainsway backs FY26 revenue view $66M-$68M, consensus $66.44M

Backs FY26 adjusted EBITDA view $12M-$14M. “We are off to an excellent start in 2026, delivering 35% revenue growth in the first quarter while generating $2.8 million of Adjusted EBITDA,” said Hadar Levy, CEO of BrainsWay (BWAY). “Across the board, we are seeing meaningful progress in expanding awareness and access to Deep TMS, driven by broader reimbursement, increasing provider adoption, and continued engagement with leading mental health networks. These efforts are translating into growing demand, increased utilization, and strong momentum across our business.”